Literature DB >> 21153353

Workshop Summary: Introduction to Rational Design of New Means for Therapeutic Modulation of Function of the TNF Family.

Klaus Pfizenmaier1, David E Szymkowski.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21153353     DOI: 10.1007/978-1-4419-6612-4_50

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation.

Authors:  Fabian Richter; Sarah K Williams; Katharina John; Carina Huber; Camille Vaslin; Henri Zanker; Richard Fairless; Kira Pichi; Silke Marhenke; Arndt Vogel; Marie-Ann Dhaen; Stefanie Herrmann; Andreas Herrmann; Klaus Pfizenmaier; Heike Bantel; Ricarda Diem; Roland E Kontermann; Roman Fischer
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

2.  A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death.

Authors:  Roman Fischer; Olaf Maier; Martin Siegemund; Harald Wajant; Peter Scheurich; Klaus Pfizenmaier
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

Review 3.  Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.

Authors:  Roman Fischer; Olaf Maier
Journal:  Oxid Med Cell Longev       Date:  2015-03-05       Impact factor: 6.543

Review 4.  Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.

Authors:  Sujuan Yang; Julie Wang; David Douglass Brand; Song Guo Zheng
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.